barr 513 (Acetazolamide Extended Release 500 mg)

Pill imprint barr 513 has been identified as Acetazolamide extended release 500 mg.

Acetazolamide is used in the treatment of mountain sickness / altitude sickness; pseudotumor cerebri; glaucoma; hydrocephalus; edema (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for barr 513

Acetazolamide extended release 500 mg barr 513
Acetazolamide extended release
Imprint:
barr
513
Strength:
500 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Carbonic anhydrase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00555-0513
Inactive Ingredients:
microcrystalline cellulose
sodium lauryl sulfate
magnesium silicate
D&C Red No. 28
D&C Yellow No. 10
FD&C Red No. 40
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Blue No. 2
propylene glycol

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)